ARGAN INC·4

Jun 12, 4:30 PM ET

Jeffrey John Ronald Jr. 4

Research Summary

AI-generated summary

Updated

ARGAN (AGX) Director Jeffrey J. Ronald Jr. Exercises & Receives TRSUs

What Happened
Jeffrey J. Ronald Jr., a director of ARGAN, had time‑based restricted stock units (TRSUs) convert/vest and received a new TRSU grant on June 10, 2026. The Form 4 shows: 533 shares acquired via conversion/exercise of a derivative at $0.00 (total value $0), a 530-share derivative disposition (reported as part of the conversion/issuance adjustments), and a grant/award of 189 TRSUs at $0.00 (total value $0). These were awards/vests, not open‑market purchases or sales.

Key Details

  • Transaction date: June 10, 2026. All reported prices $0.00; reported dollar amounts $0.
  • Reported transactions and counts: conversion/exercise (M) — 533 shares acquired; conversion/disposition (M) — 530 shares disposed (derivative); grant/award (A) — 189 TRSUs granted.
  • Shares owned after transaction: not specified in the supplied summary of the filing.
  • Footnotes: F1 — 530 TRSUs vested under a one‑year vesting schedule and were adjusted for dividends (resulting in the 533 shares reported). F2 — 189 TRSUs were granted on June 10, 2026 and will vest in full on June 10, 2027 or at the 2027 Annual Meeting, whichever is earlier.
  • Filing timeliness: Reported on Form 4 filed June 12, 2026 for a June 10, 2026 event — appears timely (Form 4 is generally due within two business days).

Context

  • Codes explained simply: M = exercise/conversion of a derivative security (here, TRSUs converting into shares); A = grant/award of restricted stock units. A $0.00 exercise/grant price indicates shares were issued as part of awards/vesting, not purchased for cash.
  • These transactions are company awards/vests and a new grant — routine equity compensation events that do not, by themselves, signal a buy/sell decision by the insider.